Patients with Sickle Cell Increase Healthy Blood Cells in New Drug Trial
A Phase 3 study has found that patients with Sickle Cell Disease (SCD) who took a daily dose of the novel drug voxelotor had less anemia and made healthier red blood cells than patients receiving a placebo.